Does Rallies show 13F holders for SNY?

Yes. Rallies tracks hedge fund and 13F ownership data for SNY, including fund names, share counts, latest tracked quarter, and position changes when available.

Is SNY research on Rallies investment advice?

No. Rallies provides research, data, and educational context for SNY. It does not provide personalized investment advice.

SNY (Sanofi American Depositary Shares (Each representing one-half of one ordinary share)) Stock Analysis - Hedge Fund Holdings

Sanofi American Depositary Shares (Each representing one-half of one ordinary share) (SNY) is a publicly traded Healthcare sector company. As of May 20, 2026, SNY trades at $44.50 with a market cap of $104.32B and a P/E ratio of 0.00. SNY moved +2.58% today. Year to date, SNY is -5.98%; over the trailing twelve months it is -15.54%. Its 52-week range spans $42.33 to $60.12. Analyst consensus is neutral with an average price target of $53.00. Rallies surfaces SNY's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns SNY stock?

Hedge funds tracked by Rallies that own SNY include Viking Global, Soros Fund, GQG Partners, Maverick Capital, and Berkshire Asset. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sanofi American Depositary Shares (Each representing one-half of one ordinary share).

SNY Key Metrics

Key financial metrics for SNY
Metric	Value
Price	$44.50
Market Cap	$104.32B
P/E Ratio	0.00
EPS	$0.00
Dividend Yield	2.42%
52-Week High	$60.12
52-Week Low	$42.33
Volume	2.60M
Avg Volume	0
Revenue (TTM)	$0
Net Income	$0
Gross Margin	0.00%

Top Hedge Funds Holding SNY

Viking Global holds 326.29K shares of SNY, changed +0.00% as of Jun 30, 2024.
Soros Fund holds 200.00K shares of SNY, changed -50.00% as of Dec 31, 2024.
GQG Partners holds 164.71K shares of SNY, changed +36.18% as of Mar 31, 2026.
Maverick Capital holds 24.58K shares of SNY, changed +0.00% as of Mar 31, 2026.
Berkshire Asset holds 4.25K shares of SNY, changed +0.00% as of Dec 31, 2023.

Latest SNY News

Sanofi/Regeneron COPD Trial Shows 27% Benefit in AERIFY-1 but Fails in AERIFY-2 — May 20, 2026
Sanofi funds AlphaDetect to expand Alpha-1 testing for over 90% undiagnosed patients — May 6, 2026
Dupixent Phase 4 Trial Shows 59% Histological Remission in EoE Patients — May 5, 2026
Sanofi ADRs slide as shares turn ex-dividend and Morgan Stanley downgrades — May 4, 2026
Regeneron Q1 revenue jumps 19% to $3.6bn, GAAP net income down 10% — Apr 30, 2026

SNY Analyst Consensus

3 analysts cover SNY: 0 strong buy, 0 buy, 3 hold, 0 sell, 0 strong sell. Consensus rating is neutral. Average price target: $53.00.

Common questions about SNY

Who owns SNY stock?: Hedge funds tracked by Rallies that own SNY include Viking Global, Soros Fund, GQG Partners, Maverick Capital, and Berkshire Asset. The latest tracked quarter is Jun 30, 2024. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Sanofi American Depositary Shares (Each representing one-half of one ordinary share).
Does Rallies show 13F holders for SNY?: Yes. Rallies tracks hedge fund and 13F ownership data for SNY, including fund names, share counts, latest tracked quarter, and position changes when available.
Is SNY research on Rallies investment advice?: No. Rallies provides research, data, and educational context for SNY. It does not provide personalized investment advice.